Page 13 - EXOSOMES
P. 13

www.advancedsciencenews.com                                                         www.small-journal.com


           nanoparticles, principally liposomes. [6,7]  Current barriers to the   nanovesicles per million cells could be isolated, [5,21,22]  thus
           clinical  use  of  biofunctionalized  nanoparticles  include  lack  of   highlighting the potential of milk as an economic and scalable
           batch  to  batch  reproducibility  and  toxicity.  Naturally  derived   source of exosomes.
           nanoparticles such as exosomes are increasingly being pro-  Transmission electron microscopy (TEM) images confirmed
           posed as an alternative to synthetic nanoparticles to overcome   a non-aggregated population of exosomes with typical “cup-
           some of those limitations, thanks to their natural origin,   shape” morphology. Large extracellular vesicles (distinguishable
           (phospho)lipid bilayer structure, and nanometric size. [8]  by their irregular shape and electron-dense appearance, [8,23]
             Among the possible sources, milk exosomes are notable for   cellular fragments, or protein clusters are often found in sus-
           their easy production and high sample volumes in comparison   pensions of isolated milk exosomes, [24]  but these contaminants
           with  culture fluid or blood  plasma. With  this approximation,   were not identified in the micrographs (Figure  1a). These
           a  high yield,  harmless,  and  cost-effective  production  of  non-  results evidence the successful combination of ultracentrifuga-
                                                          [9]
           tumor exosomes can be obtained for use as a scalable source.    tion, precipitation, and size exclusion chromatography for the
           In addition, the non-toxic  and non-immunogenic  behavior of   isolation  of  goat milk  exosomes.  The  protocol  also removes
           milk exosomes in healthy models has been demonstrated, [10,11]    other contaminants, such as milk fat.
           as has as their application as carriers for chemotherapeutic/  Quantitative measurement of the hydrodynamic size by
                             [12]
           chemopreventive agents.  Although these characteristics have   dynamic light scattering (DLS) established a mean size of
           been evaluated in exosomes from different milk sources such   125.70 ± 3.25 nm (Figure 1b), with a polydispersity index of 0.14,
           as human, pig, rat, camel, and horse,  to the authors’ knowl-  confirming a monodisperse suspension of exosomes. Nanopar-
                                        [8]
           edge goat milk exosomes have not yet been investigated.  ticle tracking analysis (NTA) showed modal average values of
             Aside from the great potential of EVs in cancer therapy, [5,6]    124.44 ± 8.54 nm, similar to the results achieved by DLS. This
           milk exosomes have been implicated in the regulation of   size distribution matches the profile described for exosomes
                                                    [13]
           inflammatory processes through miRNA trafficking.  More-  isolated from cow milk, one of the most employed sources for
           over, milk exosomes are rapidly trapped by macrophages [14,15]  as   the collection of milk extracellular vesicles. [12,25]  NTA also dem-
           part of the clearance activity that these cells, along with neu-  onstrated the high content of nanovesicles in the exosome sus-
                                                                                                             11
                                                                                                  11
           trophils, carry out when foreign agents are detected. [16–18]  This   pension, reporting a concentration of 3.32 × 10  ± 3.25 × 10
                                                                       −1
           natural targeting and their nanometric size support the use   particles mL  (Figure 1c).
           of milk exosomes in the diagnosis and therapy of inflamma-
           tion  underlying the  pathogenesis of  diseases such  as  athero-
           sclerosis, chronic obstructive pulmonary disease, asthma, and   2.2. Proteomic Evaluation of Milk Exosomes
           cancer. [19,20]
             The main aims of this work were a full physicochemical   To determine the composition of milk exosomes, extensive
           characterization of exosomes isolated from goat milk and their   LC-MS/MS proteomic analyses were performed. A total of ≈900
           further evaluation for use as natural nanoprobes in the detec-  proteins  (derived  from  ≈4500  peptides)  were  identified in  all
           tion of inflammatory processes. This evaluation was performed   three independent isolations of goat milk exosomal samples.
           through their fluorescent labeling and further in vitro and in   GO analyses using the top 100 most abundant proteins
           vivo assessment by means of optical imaging. The internaliza-  revealed enrichment in terms such as extracellular exosome,
           tion of these fluorescent exosomes in inflammatory M0, M1,   extracellular region part, vesicle, and membrane-bounded ves-
           and M2 macrophages in vitro was evaluated by means of con-  icle, confirming the identity of the samples as EVs (Figure S1,
           focal imaging and flow cytometry. Once the capacity of mac-  Supporting Information).
           rophages to internalize the exosomes was demonstrated  in   In addition, PANTHER overrepresentation analyses
           vitro, it was evaluated in vivo in a mouse peritonitis model in   showed that the identified proteins were involved in pro-
           comparison with healthy mice by assessing the biodistribution   cesses such as neutrophil degranulation, the innate immune
           of the probe through optical imaging. Finally, exudates from   system, the immune system, hemostasis, and platelet activa-
           the peritonitis model were analyzed using flow cytometry and   tion. This kind of activity related to the immune system has
           confocal imaging to confirm the in vivo uptake of the nanopar-  been described for other milk-derived exosomes. [25]  A 15-fold
           ticles by specific inflammatory cell populations (macrophages   or greater enrichment was observed for the ECRT (endosomal
           and neutrophils).                                  sorting complex required for transport), endosomal/vacuole
                                                              pathway, and regulation of the complement cascade, among
                                                              others.
           2. Results and Discussion                            Similarly, proteins were involved in several molecular
                                                              functions including membrane transport and binding activity,
           2.1. Isolation and Characterization of Milk Exosomes  protein transport, vesicle-mediated transport, adhesion, or met-
                                                              abolic processes. These kinds of processes are related to general
           Our isolation protocol enabled us to collect pure goat’s milk   cell function and growth or to the endocytic pathway of the vesi-
                                                 −1
           exosomes in suspension at 2.29  ± 0.25  mg mL , as quanti-  cles themselves. Other processes such as endosomal transport
           fied by Coomassie-Bradford assay, from an initial goat’s milk   via the multivesicular body sorting pathway, that pathway itself,
           volume of 60 mL. Previous publications detailing exosome iso-  late endosome-to-vacuole transport, and response to reactive
           lation techniques from culture media of dendritic and murine   oxygen species were enriched more than tenfold. Cellular com-
           tumor cell lines have reported that only 0.2–2.0  µg of these   partment results showed an over-representation of “endosome”;



           Small 2021, 2105421             2105421  (2 of 12)              © 2021 The Authors. Small published by Wiley-VCH GmbH
   8   9   10   11   12   13   14   15   16   17   18